solid malignancies
Showing 1 - 25 of 9,792
Solid Malignancies Trial (Tisotumab Vedotin)
Not yet recruiting
- Solid Malignancies
- Tisotumab Vedotin
- (no location specified)
May 9, 2023
Head Neck Cancer, Cervical Cancer, Endometrial Cancer Trial (ILB-2109, Toripalimab)
Not yet recruiting
- Head and Neck Cancer
- +9 more
- (no location specified)
Jul 12, 2023
Advanced Solid Tumors Cancer, Advanced Urothelial Carcinoma, Oral Drug Administration Trial in New York (FX-909)
Not yet recruiting
- Advanced Solid Tumors Cancer
- +3 more
-
New York, New YorkMemorial Slone Kettering Cancer Center
Jun 26, 2023
Solid Tumor Trial in Tokyo (GEN1046)
Recruiting
- Solid Tumor
- GEN1046
-
Tokyo, Japan
- +1 more
Jan 13, 2023
Solid Malignancies or Lymphomas Trial in Wollongong (IBI363)
Recruiting
- Solid Malignancies or Lymphomas
- IBI363
-
Wollongong, New South Wales, AustraliaSouthern Medical Day Care Centre
Sep 4, 2022
Tumor Rebiopsy in Children and Recurrent or Progressive Solid
Active, not recruiting
- Tumor, Solid
- Re-biopsy
- Questionnaire
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 10, 2022
PTEN-null Advanced Solid Tumors Trial in New York (Leflunomide)
Not yet recruiting
- PTEN-null Advanced Solid Tumors
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jul 8, 2022
Advanced Solid Malignancies Trial in Kogarah, Macquarie, Frankston (YH002)
Completed
- Advanced Solid Malignancies
-
Kogarah, New South Wales, Australia
- +2 more
Jul 21, 2022
Solid Tumor, Tumors Trial in Lund, Solna, Uppsala (ATOR-1017)
Active, not recruiting
- Solid Tumor
- Neoplasms
- ATOR-1017
-
Lund, Sweden
- +2 more
Aug 16, 2022
COVID-19 on Solid Malignancies: A Single-Institution Survey
Recruiting
- Solid Tumor
- Questionnaire
-
Manchester, Greater Manchester, United KingdomThe Christie NHS Foundation Trust
May 3, 2022
Advanced Malignant Solid Tumor, Extracranial Solid Tumor, Metastatic Malignant Solid Tumor Trial in Palo Alto (Anti-OX40
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Anti-OX40 Antibody BMS 986178
- TLR9 Agonist SD-101
-
Palo Alto, CaliforniaStanford Cancer Institute Palo Alto
Jun 13, 2022
Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Houston (NTX-1088, Pembrolizumab)
Recruiting
- Cancer
- +4 more
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Jan 24, 2023
Solid Tumor, Tumors Trial in Denmark, Sweden (ATOR-1015)
Completed
- Solid Tumor
- Neoplasms
- ATOR-1015
-
Copenhagen, Denmark
- +4 more
Aug 16, 2022
Solid Tumor, Lymphoma Trial in Los Angeles (DZ-002)
Recruiting
- Solid Tumor
- Lymphoma
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Mar 2, 2022
